MétaCan
← tous les travaux

Correction: Current application status of non-invasive brain stimulation techniques in Alzheimer's disease: a bibliometric analysis

2025· article· en· 0 citations· W4416390184 sur OpenAlex· 10.3389/fnagi.2025.1730649

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Porte sur le CanadaSon objet est le Canada, où que soient ses auteurs.

Aucune affiliation canadienne. Une base fondée sur la seule affiliation (le devis habituel) n'aurait jamais vu ce travail. C'est l'un des travaux qui justifient l'inversion de la base.

Le tri à trois modèles

les 1 000 travaux triés →

Les trois modèles l'ont jugé hors champ.

strate : about_only · poids de sondage : 3321.24 (l'échantillon est stratifié ; tout taux calculé sans le poids est faux)
Claude Opus 4.8T3 · adjacent, hors champ
genre : other
porte sur le Canada: non
confiance: medium

Correction notice attached to a bibliometric analysis of the brain-stimulation literature in Alzheimer disease; corrections are contextual, though the underlying work is a bibliometric study of a research literature.

GPT-5.6 (high)T3 · adjacent, hors champ
genre : other
porte sur le Canada: non
confiance: high

This is a correction to a bibliometric article and is contextual rather than part of the analytic corpus.

Grok 4.5T3 · adjacent, hors champ
genre : other
porte sur le Canada: non
confiance: high

Published correction notice; corrections are mapped as T3 even if the corrected paper was bibliometric.

Résumé

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder, which will affect 150 million individuals worldwide by 2050, positioning AD as a critical public health challenge (De Paolis et al., 2024;Yan et al., 2024). Despite substantial research focused on elucidating the pathogenesis of AD, identifying biomarkers for early diagnosis, and developing effective treatments, the intricate pathophysiological mechanisms underlying the disease remain incompletely understood. Current medication therapeutic mainly include acetylcholinesterase inhibitors (e.g., Donepezil, Galantamine), NMDA receptor antagonists (e.g., Memantine), and anti-amyloid-β monoclonal antibodies (e.g., Lecanemab, Donanemab, Aducanumab), these drug intervention limited efficacy, and prone to adverse reactions (Liang et al., 2024;Haque and Levey, 2019), which seriously impacts the quality of life of middle-aged and elderly adults. To date, no treatment capable of achieving complete recovery has been developed (Wojtecki et al., 2024;Petrovskaya et al., 2023), highlighting the urgent need to develop innovative therapeutic strategies for treating AD.Non-invasive brain stimulation (NIBS) has emerged as a safe neuromodulatory approach with potential applications in neurodegenerative diseases, and has become a major research focus in various fields in recent years (Yang et al., 2024). Techniques such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcutaneous auricular vagus nerve stimulation (taVNS), photobiomodulation, and transcranial ultrasound/pulse stimulation have demonstrated promise in modulating neural excitability and plasticity. Among these, TMS (Lefaucheur et al., 2020;Georgopoulou et al., 2024) and tDCS (Teselink et al., 2021;Chen et al., 2022) are the most widely studied. Clinical evidence suggests NIBS may enhance early AD diagnosis and cognitive rehabilitation by influencing neuroplasticity (Kim S. K. et al., 2024;Kim T. et al., 2024;Manippa et al., 2024;Elahi and Frechette, 2023;Benussi et al., 2022;Yao et al., 2022). However, its long-term efficacy and precise mechanisms require further exploration.Bibliometric analysis, supported by tools like CiteSpace, enables quantitative and qualitative evaluation of research trends, hotspots, and collaborative networks within a field (Zhang et al., 2023). With its robust analytical capabilities, it enables researchers to systematically map research trajectories and identify emerging research frontiers, making it an invaluable tool for advancing scientific discovery (Zhang et al., 2024). Current bibliometric studies on AD predominantly focus on analyzing research hotspots and influencing factors (Liu et al., 2019;Shi et al., 2022;Yue et al., 2022). While NIBS ameliorates cognitive impairments in AD by enhancing neuroplasticity, strengthening neurovascular coupling, and attenuating neuroinflammation (Pievani et al., 2017;Lefaucheur et al., 2020;Ferrucci et al., 2008), there remains a significant scarcity of integrative bibliometric analyses comparing the therapeutic efficacy of different NIBS modalities. This study employs CiteSpace to analyze NIBS-AD research, providing insights into current advancements, emerging hotspots and trends. It also lays the groundwork for future research and clinical applications, exploring emerging frontiers and translational potential of NIBS in AD research, thereby, informing evidencebased clinical practice.The data utilized in this study were retrieved from the Science Citation Index Expanded (SCI-E) within the Web of Science Core Collection (WOSCC) database. The search strategy was designed as follows: TS = ("Alzheimer's disease" OR "Alzheimer disease") AND TS = ("non-invasive brain stimulation" OR "non-invasive neuromodulation technology" OR "transcranial direct current stimulation" OR "transcranial magnetic stimulation" OR "transcranial ultrasound stimulation" OR "transcutaneous auricular vagus nerve stimulation" OR "transcranial alternating current stimulation" OR "transcranial pulse stimulation"). The time span was set from the establishment of the database to November 27, 2024, and the language was restricted to English. Following the initial search, all retrieved publications were systematically screened by reviewing their titles and abstracts. Publications that did not meet the inclusion criteria were excluded. The process was independently performed by two reviewers, and the third reviewer reviewed the studies with ambiguity. The included studies were randomized controlled trials, cohort studies, prospective studies, etc., covering search-based AD and NIBS. The screening process is shown in Figure 1.The analysis and visualization of results in this study were conducted using the following software tools: CiteSpace 6.3.3.0, GraphPad Prism 10.4.1, VOSviewer 1.6.20, Microsoft Excel 2021, and NoteExpress 1.0.0.0. The analytical framework encompassed multiple dimensions, including publication trends, journal distribution statistics, country/region and institutional collaboration networks, author and co-cited author networks, co-citation document networks, as well as keywords and research hotspot analysis. These tools and methods were employed to provide a comprehensive and systematic overview of the research landscape.Following data import into CiteSpace and VOSviewer. The VOSviewer was set to the maximum number of countries per document to 25, and the minimum number of documents per country to>5. The CiteSpace was set to have a time range spanning 1999-2024 with 1-year slicing intervals. Key selection parameters 3 ResultsA total of 632 NIBS-AD studies were identified in the WOSCC database. Publication trends (Figure 2) revealed low interest in NIBS-AD applications prior to 2000, followed by a surge during 2020-2021. Following 2021, the rate of publication growth decelerated. However, the annual number of publications continues to rise, indicating sustained research activity in the field.Table 1 lists the top 10 journals by publication output for NIBS-AD research, along with their corresponding impact factors (updated to 2023 via the WOS database), providing critical references for researchers in this field. The Journal of Alzheimer's Disease ranked first, publishing 44 NIBS-AD-related articles, with an annual output exceeding 700 articles and an impact factor of 3.4. The second-ranked journal, Frontiers in Aging Neuroscience, contributed 37 NIBS-AD publications. In 2024, the journal published over 1,400 articles, representing a notable rise compared to 2023, with its publication output remaining on an upward trajectory. The journal holds an impact factor of 4.1, reflecting its growing influence in the field of aging neuroscience. Clinical Neurophysiology ranked third with 27 NIBS-AD publications, maintaining an average annual output of ~85 articles over the past decade and an impact factor of 3.7. It is evident that articles focusing on NIBS-AD are more commonly featured in journals specializing in Alzheimer's disease, as well as in professional periodicals dedicated to neurological disorders. And the impact factors are mostly concentrated in 3-4 points.The distribution of the top 10 research categories in this field reveals that Neuroscience leads with 421 publications, followed by Clinical Neurology (234 publications), collectively accounting for over half of the total. This indicates that NIBS-AD research primarily focuses on fundamental and clinical aspects related to the nervous system. Categories such as geriatric medicine and gerontology (92 publications) and psychiatry (68 publications) also hold significant proportions, reflecting close connections with interdisciplinary fields like aging and mental health. The overall landscape demonstrates a core focus on neuroscience and clinical neurology while extending into multidisciplinary intersections (as shown in Figure 3).From the dual-map overlay analysis of journals (Figure 4), the left region represents the set of citing journals, while the right region represents the set of cited journals. The colored pathways connecting the two regions illustrate citation relationships across diverse research fields. Notably, two prominent yellow citation pathways highlight that research published in molecular, biological, and immunology journals predominantly cites content from molecular, biology, and genetics research journals, as well as psychology, education, and social research journals. This reflects the foundational role of basic biomedical sciences in AD research, while highlighting its multidisciplinary focus on patients' cognitive-behavioral profiles and psychosocial functioning. Crucially, it demonstrates substantive interconnections across research domains, thereby providing a broader perspective for analyzing and understanding the complex pathophysiological mechanisms and clinical intervention strategies of AD.A total of 29 countries met the inclusion criterion of publishing more than five articles, which were categorized into five clusters according to their collaborative intensity. The top five countries contributing the most to the research output were Italy (centrality = 0.16), China (centrality = 0), the United States (centrality = 0.34), Canada (centrality = 0.06), and Spain (centrality = 0.11). The publications from the United States and Italy exhibited the highest citation centrality, reflecting their relatively significant academic impact. China initiated its research on this field in 2010, despite a substantial number of publications, the citation frequency of these studies remains relatively low, thereby limiting their academic influence. This likely stems from constrained collaborative engagement between Chinese researchers and globally leading institutions, limiting international visibility and discourse of their findings, consequently diminishing citation impact within the scholarly community (Figures 5,6).Table 2 presents the top ten institutions with the highest number of published papers in this field. Centrality is often associated with an institution's connectivity within collaborative networks. While Harvard Medical School (centrality = 0.07) leads in paper publications, Sapienza University of Rome (centrality = 0.37) ranks second with the highest citation centrality. This may be attributed to the institution's extensive collaborations with internationally renowned entities, which position its research achievements as pivotal nodes in collaborative networks, thereby demonstrating significant academic influence. Figure 7 displays a global collaborative network map among these institutions.This study identified 529 authors contributing to NIBS-AD research. Figure 8 maps global collaboration networks, while publication metrics reveal top scholars: Giacomo Koch Country co-occurrence map. Analysis of cited references (Figure 10) revealed that the article by Koch et al. (2018), titled "Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease, " published in Neuroimage in 2018, was identified as the most cited (87 citations). This study demonstrates that high-frequency transcranial magnetic stimulation targeting the precuneus significantly enhances brain network connectivity and memory function in AD patients. Figure 11 Figure 12 illustrate the keyword co-occurrence network in this study. The most frequent keywords were "Alzheimer' s disease" (378 occurrences), "transcranial magnetic stimulation" (284 occurrences), "mild cognitive impairment" (161 occurrences), "memory" (92 occurrences), and "dementia" (92 occurrences). And the color change of the line between the keywords represents the time change of their respective occurrence, and the color change from bottom to top represents the distance of the research time. The red line indicates the recent trend. Over time, research trends have evolved significantly. Notably, the diversification of keywords related to NIBS has expanded the scope of research topics, with TMS, tDCS, tACS, and synaptic plasticity continuing to dominate the research landscape in this field.Figure 13 illustrates the thematic clusters formed by keywords. The red cluster centered on "transcranial magnetic stimulation" represents the largest research sector within this network. Significantly, the top three keywords in this cluster perfectly align with those most frequently identified in comprehensive analyses, highlighting their central role in the research landscape. Moreover, the 10 clusters are roughly divided into three directions: neurodegenerative diseases, theory and application of NIBS technology, intervention methods and mechanisms, reflecting the multi-level research pattern of "technology development-disease application-mechanism exploration" in the field.Figure 14 presents the top 20 burst keywords based on burst strength. The keyword "human motor cortex, " which emerged in 2005, demonstrated the highest burst strength (9.29), with its burst activity spanning from 2007 to 2019. This was followed by "motor cortex excitability, " which appeared in 2001 and demonstrated the longest burst duration (13 years) with a burst strength of 7.81. Notably, "impairment" and "non-invasive brain stimulation" emerged as burst keywords in 2022 and continue to exhibit burst activity to the present. This analysis This study analyzed research articles related to the specific applications of NIBS in AD from the establishment of the WOSCC database up to November 27, 2024. Data analysis and visualization were conducted using Microsoft Excel, CiteSpace, GraphPad Prism, VOSviewer, and NoteExpress software to facilitate a comprehensive and visually accessible understanding of the current research landscape, hotspots, and emerging trends in the application of NIBS for AD. By contrasting previous analyses of single NIBS technologies, the results of this study fill the comprehensive application research gap in comprehensive NIBS application research for AD, and provide ideas for future mechanism research and clinical treatment in this field.Literature analysis shows that research related to NIBS-AD presents a generally upward trend, with the most significant growth rate during 2020-2021. Based on the analysis results of annual publication rankings, countries, institutions, and authors, the top three journals publishing NIBS-AD studies were Journal of Alzheimer's Disease, Frontiers in Aging Neuroscience, and Clinical Neurophysiology. Multiple countries have contributed to this field, with Italy, China, and the United States leading in publication output. Among them, Italy and the United States rank first in the world in terms of the number of papers published and have high citation centrality, indicating that they occupy a leading position in promoting NIBS-AD research. Italy's leading position is closely related to its longterm research accumulation, continuous investment from key institutions (such as Sapienza University of Rome, Univ Roma Tor Vergata), and academic cooperation networks of professionals (such as Giacomo Koch, Martorana, A, Di Lorenzo, F). China started relevant research in 2010, and the number of papers has increased sharply. However, the citation frequency of these achievements is relatively low, which may be related to the high proportion of selfcitation patterns and language differences. The co-occurrence maps of countries, institutions, and authors show that the global cooperation network has been increasingly strengthened in recent years. To further promote in-depth research on NIBS-AD, interdisciplinary collaboration between leading institutions in various countries is crucial. At the same time, China should strengthen exchanges and Author co-occurrence map. Cong et al. 10.3389/fnagi.2025.1585885 Frontiers in Aging Neuroscience 10 frontiersin.org cooperation with top international institutions to improve its academic influence in this field.Combined with high-frequency keywords, keyword clustering, and keyword burst detection, within the analyzed time range, "motor cortex excitability" maintained the longest duration of research interest (13 years, 2001-2014), while "human motor cortex" demonstrated the highest burst strength (9.29). Over time, the research focus has shifted from early exploration of basic physiological functions such as "human motor cortex" and "motor cortex excitability" to discussions on the expanded application of non-invasive technologies, as well as disease-related intervention measures and mechanisms. For example, the targeted intervention of AD using technologies like TMS and tDCS, and their improving effects on neuroplasticity, cerebral blood flow and metabolism, neuroinflammation, and brain networks. Current bibliometric analysis indicates that while numerous NIBS-AD clinical trials prioritize immediate cognitive metrics, critical evidence gaps remain regarding long-term treatment sustainability. Cluster analysis reveals fundamental fragmentation in mechanistic research. As shown in Figure 13, clusters labeled "neuromodulation" (Cluster #6), "cognitive training" (#7), and "default mode network" (#8) demonstrate lower connectivity compared to the overall dataset, reflecting persistent gaps between preclinical and clinical evidence validation in neuroplasticity research. The emergent keywords "impairment" and "non-invasive brain stimulation" in 2022 mark the official shift of research focus to "pathological injury repair" and "multimodal technology integration, " providing new targets for Phase III clinical trials, and ultimately a research and treatment of research and development-disease therapeutic potential for AD mechanisms that enhance neuroplasticity, and cerebral blood flow co-occurrence and burst analyses reveal that TMS and tDCS the NIBS for AD, with transcranial alternating current stimulation emerging as an TMS a magnetic field that and thereby neural This process neuroplasticity, as well as synaptic plasticity. the tDCS the thereby excitability and neural research indicates that NIBS enhance the of such as metabolism, and excitability, collectively contributing to the of cognitive functions and in AD et al., and et al., et al., By on the cerebral cortex, not also plasticity. indicates efficacy of over stimulation parameters (Kim S. K. et al., 2024;Kim T. et al., et al., 2024). In TMS targeting the motor cortex for the of excitability and neuroplasticity et al., et al., et al., has revealed that in AD cognitive is significantly associated with increased excitability, and more impairments in plasticity et al., 2022). of may to early However, it should be that TMS in excitability than the of pathophysiological further blood are for also demonstrates significant therapeutic efficacy in Alzheimer's disease (AD) Clinical evidence indicates that tDCS enhances memory in AD with intervention improving by et al., et al. also these findings, that left cortex significantly memory and function et al., study by the that five of on the cortex of AD their in the memory significantly This demonstrated the of on improving memory et al., analyses revealed connectivity between the mode network and network of brain networks critical for cognitive et al., et al., et al., the of the of clinical studies should be to the treatment mode co-occurrence cluster of the top 20 keywords. Cong et al. 10.3389/fnagi.2025.1585885 Frontiers in Aging Neuroscience 14 frontiersin.org with et al., 2022). Notably, and memory as demonstrated across multiple et al., et al., et al., et al., The as the for integration, shows in AD that neural connectivity and via effects by synaptic and and and These collectively position as strategies for and connectivity in prodromal AD. these results and as effective treatment for AD to a while stimulation should be by more clinical trials to analysis revealed Giacomo article "Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease" as the publication et al., The precuneus in the a role in memory and as a key in the mode network. that targeting the a non-invasive for memory in Alzheimer's disease patients. This study the as a during and it as an for to memory At the same time, while with enhancing memory et al., et al., 2022). randomized controlled also that and sustained cognitive in memory et al., has been that AD treatment targets the cortex and the precuneus The the most frequently targeted region in research, while pivotal in cognitive functions including cognitive and memory et al., et al., et al. demonstrated that AD exhibited and et al., While stimulation enhances connectivity within brain networks, demonstrates efficacy in global memory immediate and et al., et al., et al., et al., tDCS targeting also therapeutic Multiple studies have demonstrated that transcranial direct current stimulation targeting the left ameliorates cognitive impairments in AD including and memory and significant effects et al., et al., et al., 2022). study by et al. demonstrated that targeting the left with tDCS over the right excitability, neuroplasticity impairments and enhancing cognitive in elderly et al., evidence has demonstrated that targeting the and stimulation holds However, significant among future research should focus on stimulation targets and while exploring to treatment It is to further such as magnetic and to identify therapeutic targets for study has the search was restricted to the WOSCC database and included studies, leading to the of relevant studies and the of a systematic quality of the included that the of (e.g., disease" and "Alzheimer disease") was not during the analysis to in the bibliometric The direct of data from WOSCC with the of analytical tools and to may have analytical no analysis was conducted to specific stimulation and there is limited exploration of the clinical and of research should prioritize clinical trials, a broader range of Moreover, the key for should be according to the international and comprehensive analyses of their study a comprehensive overview of the research hotspots, and trends in the application of NIBS for AD. that the current research hotspots predominantly focus on the effects of various NIBS on cognitive function in AD, the selection of treatment and the underlying mechanisms. Based on the findings, this field is significant and To further the field, global collaboration among countries, institutions, and researchers is to scientific and clinical

Conservé avec la notice de tri, où il sert de preuve aux étiquettes ci-dessus.

La notice

Revue
Frontiers in Aging Neuroscience
Thématique
Neurological disorders and treatments
Domaine
Medicine
Établissements canadiens
Organismes subventionnaires
Mots-clés
Current (fluid)Brain stimulationStimulationTranscranial direct-current stimulationElectroencephalography
Résumé présent dans OpenAlex
oui